150 related articles for article (PubMed ID: 16286946)
1. What's happening in PHARMAC--where do all the submissions go? On the trail of gemcitabine.
Simpson A
N Z Med J; 2005 Nov; 118(1225):U1733. PubMed ID: 16286946
[TBL] [Abstract][Full Text] [Related]
2. PHARMAC's response on gemcitabine and transparency.
Crausaz S; Metcalfe S
N Z Med J; 2005 Nov; 118(1225):U1741. PubMed ID: 16286949
[No Abstract] [Full Text] [Related]
3. Toxic epidermal necrolysis associated with gemcitabine therapy in a patient with metastatic transitional cell carcinoma of the bladder.
Mermershtain W; Cohen AD; Lazarev I; Grunwald M; Ariad S
J Chemother; 2003 Oct; 15(5):510-1. PubMed ID: 14598945
[TBL] [Abstract][Full Text] [Related]
4. [Toxicity of intravesical gemcitabine in superficial bladder cancer treatment].
Beardo Villar P; Gamaza Martínez R; Gavira Moreno R
Farm Hosp; 2014 May; 38(3):249-51. PubMed ID: 24951911
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of the bladder.
Campodonico F; Maffezzini M
Urology; 2005 Nov; 66(5):1141-2; author reply 1142. PubMed ID: 16286156
[No Abstract] [Full Text] [Related]
6. Chemotherapy for advanced bladder carcinoma: new molecules and regimens.
Abi-Aad AS
Acta Urol Belg; 1996 May; 64(2):43-5. PubMed ID: 8701810
[No Abstract] [Full Text] [Related]
7. [Gemcitabine in advanced bladder cancer].
Lehmann J; Retz M; Lippert C; Albers P; Stöckle M
Urologe A; 2003 Jan; 42(1):63-77. PubMed ID: 12574885
[TBL] [Abstract][Full Text] [Related]
8. Antineoplastic effect of gemcitabine in an animal model of superficial bladder cancer.
Nativ O; Dalal E; Laufer M; Sabo E; Aronson M
Urology; 2004 Oct; 64(4):845-8. PubMed ID: 15491745
[TBL] [Abstract][Full Text] [Related]
9. [Elevation of CA 19.9 in urothelial bladder cancer].
Bastos Oreiro M; López Rodríguez M; Monedero Martín MC; Plasencia Rodríguez C
Med Clin (Barc); 2008 Mar; 130(8):319. PubMed ID: 18358126
[No Abstract] [Full Text] [Related]
10. Gemcitabine in bladder cancer.
Sternberg CN
Semin Oncol; 2000 Feb; 27(1 Suppl 2):31-9. PubMed ID: 10697034
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of bladder: Phase I-II study on marker lesions.
Serretta V; Galuffo A; Pavone C; Allegro R; Pavone-MacAluso M
Urology; 2005 Jan; 65(1):65-9. PubMed ID: 15667865
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine and other new chemotherapeutic agents for the treatment of metastatic bladder cancer.
Vogelzang NJ; Stadler WM
Urology; 1999 Feb; 53(2):243-50. PubMed ID: 9933034
[TBL] [Abstract][Full Text] [Related]
13. Intravesical gemcitabine therapy for superficial transitional cell carcinoma of the bladder: a phase I and pharmacokinetic study.
Laufer M; Ramalingam S; Schoenberg MP; Haisfield-Wolf ME; Zuhowski EG; Trueheart IN; Eisenberger MA; Nativ O; Egorin MJ
J Clin Oncol; 2003 Feb; 21(4):697-703. PubMed ID: 12586808
[TBL] [Abstract][Full Text] [Related]
14. [The role of gemcitabine in the treatment of bladder tumors].
Cortesi E; Gareri R
Clin Ter; 1999; 150(1):5-6. PubMed ID: 10367537
[No Abstract] [Full Text] [Related]
15. Toxic effects and antitumor response of gemcitabine in combination with piroxicam treatment in dogs with transitional cell carcinoma of the urinary bladder.
Marconato L; Zini E; Lindner D; Suslak-Brown L; Nelson V; Jeglum AK
J Am Vet Med Assoc; 2011 Apr; 238(8):1004-10. PubMed ID: 21492043
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine for unresectable, locally advanced or metastatic bladder cancer.
Shelley M; Cleves A; Wilt TJ; Mason M
Cochrane Database Syst Rev; 2011 Apr; (4):CD008976. PubMed ID: 21491413
[TBL] [Abstract][Full Text] [Related]
17. Intravesical gemcitabine: an update of clinical results.
Hendricksen K; Witjes JA
Curr Opin Urol; 2006 Sep; 16(5):361-6. PubMed ID: 16905983
[TBL] [Abstract][Full Text] [Related]
18. Double diagnosis in cancer patients and cutaneous reaction related to gemcitabine: CASE 3. Photo therapy recall with gemcitabine following ultraviolet B treatment.
Badger J; Kang S; Uzieblo A; Srinivas S
J Clin Oncol; 2005 Oct; 23(28):7224-5. PubMed ID: 16192608
[No Abstract] [Full Text] [Related]
19. Long-term survival under maintenance gemcitabine chemotherapy for metastatic transitional cell carcinoma.
Lehmann J; Retz M; Siemer S; Schreier U; Zwergel U; Stöckle M
Int J Urol; 2006 Jul; 13(7):1035-6. PubMed ID: 16882086
[TBL] [Abstract][Full Text] [Related]
20. Intravesical therapy for superficial cancer: need for more options.
Crawford ED
J Clin Oncol; 2002 Aug; 20(15):3185-6. PubMed ID: 12149286
[No Abstract] [Full Text] [Related]
[Next] [New Search]
